New Drugs and Therapeutics Update: Sogroya® (somapacitan-beco) Injection Prepared by Daniel Mak, MD; Edited by Neha Patel, DO On February 27th, 2026, the FDA approved Sogroya®…
Depo-Provera® and Increased Risk of Meningioma: FDA-Label Update Written by: Anna Ryabets-Lienhard, DO as part of Drugs and Therapeutics Committee In December 2025, the U.S. Food and…
Navepegritide (Yuviwel®) for Children with Achondroplasia: New Drugs and Therapeutics Written by Anna Ryabets-Lienhard, DO Edited by Neha Patel, DO and Emily Breidbart, MD On February…
New Drugs and Therapeutics Update: DESMODA™ (desmopressin acetate) Oral Solution Prepared by Daniel Mak, MD DESMODA® (desmopressin acetate) Oral Solution On February 25th, 2026, the FDA…
Mounjaro (tirzepatide) approved in Pediatrics Prepared on behalf of PES Drugs and Therapeutics Committee by, Evan Graber, DO, Emily Breidbart, MD, and Neha Patel, DO. Based on…
KHINDIVI™ (hydrocortisone) Oral Solution In May 2025, the FDA approved KHINDIVI™ (hydrocortisone) Oral Solution for the treatment of adrenal insufficiency (AI) in pediatric patients ages 5…
Omnipod® 5 App now compatible with Dexcom G7 As of June 2025, the Omnipod® 5 App for iPhone is compatible with the Dexcom G7 Continuous Glucose Monitoring (CGM)…
New Drugs and Therapeutics Update: INVOKANA® (canagliflozin) Prepared by Preneet Cheema Brar, MD, MS and Daniel Mak, MD. INVOKANA® (canagliflozin) In December 2024, the FDA…
New Drugs and Therapeutics Update: VYKAT™ XR (diazoxide choline) Prepared on behalf of PES Drugs and Therapeutics Committee by Dania Al-Hamad, MD, and Neha Patel, DO. …
New Drugs and Therapeutics Update CRENESSITY (crinecerfont) capsules and oral solution On December 13, 2024, the FDA approved CRENESSITYTM (crinecerfont) as adjunctive treatment to glucocorticoid replacement…